W. Grant Stevens, M.D.

Dr. Stevens is board certified by the American Board of Plastic Surgery and is a clinical professor of plastic surgery at the University of Southern California, chairman of the USC-Marina Aesthetic Surgery Fellowship and director of the USC Division of Aesthetic Surgery. He is a fellow of the American College of Surgeons and the International […]

Read More

Michael Krychman, M.D.

Dr. Krychman is Executive Director, President, and CEO of the Southern California Center for Sexual Health and Survivorship Medicine and Associate Clinical Professor at the University of California, Irvine, Department of Obstetrics and Gynecology. He is a Member of the International Society for the Study of Women’s Sexual Health (ISSWSH), The International Society for Sexual […]

Read More

Sharon C. Presnell, Ph.D.

Dr. Presnell was appointed to the Viveve Board of Directors in October of 2020. She has over 25 years of experience in the leadership of R&D and the commercial translation of technology. Dr. Presnell currently serves as the president of the Amnion Foundation, a not-for-profit organization dedicated to the ethical preservation and utilization of birth […]

Read More

Arlene M. Morris

Ms. Morris joined the Viveve Board in May 2016. She currently serves as the chief executive officer of Willow Advisors LLC, a position she has held since May 2015. Ms. Morris was previously the chief executive officer and president of Syndax Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of an epigenetic […]

Read More

Debora Jorn

Ms. Jorn has served as a member of the Viveve Board of Directors since May 2016. She has 30 plus years of commercial experience building global pharmaceutical, aesthetics, and OTC businesses. Recognized as a leader in creating new markets she has successfully launched products in numerous therapeutic areas. Ms. Jorn has an extensive background in […]

Read More

Steven Basta

Mr. Basta joined the Viveve board in September of 2018 and was appointed as Chairman in January 2019. He most recently served as chief executive officer of Mahana Therapeutics, Inc., a privately-held digital therapeutics company. From September 2015 to March 2020, Mr. Basta served as president, chief executive officer, and director of Menlo Therapeutics, Inc., […]

Read More

Lori McMillan

Ms. McMillan joined Viveve in 2017 as Vice President of Human Resources. She joined the Company with over 20 years of leadership experience in human resources and strategic talent management in the healthcare and technology industries. Prior to joining Viveve, she served six years as Vice President of Talent Management and Chief Administrative Officer at […]

Read More

Gary Kaiser

Mr. Kaiser joined Viveve in 2019 and assumed the leadership role as Vice President of Global Marketing in January 2021. He has more than 25 years of senior management experience in the health care, pharmaceutical, and medical device industries. Prior to joining Viveve, Mr. Kaiser worked at Aytu BioScience from July 2016 to January 2019, […]

Read More

Jeff Sinclair

Mr. Sinclair, Vice President of International Sales, joined Viveve in April 2015 with over 20 years of international distributor management and direct operational experience for medical device and aesthetic companies, with a focus in Asia. His success in building and managing diverse international teams in sales, business development, marketing, and training earned him promotions from […]

Read More

Larry Lewis

Mr. Lewis, Vice President of U.S. Sales, joined Viveve in December 2016 as the Western U.S. and Canadian Director of Sales. In this position, Mr. Lewis and his team led the U.S. in new Viveve System placements and revenue in 2017 and 2018. In August 2019, he was promoted to Senior Director of Customer Care. […]

Read More

Product Indications

Viveve System
The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States.
Viveve Solutions
The Viveve System is indicated for general surgery for electrocoagulation and hemostasis in the United States. The InControl Products (InToneMV) is indicated for the treatment of all forms of urinary incontinence in the United States and Canada.